$HZNP News Article - Horizon Therapeutics plc Initiates MIRROR Randomized Controlled Trial Evaluating KRYSTEXXA (pegloticase injection) in Combination with Methotrexate to Increase Response Rates and Duration of Therapy
https://marketwirenews.com/news-releases/hori...88462.html